AMN Healthcare Presents 2026 Outlook and Long-Term Growth Model at J.P. Morgan Conference

summarizeSummary

AMN Healthcare presented its 2026 outlook and long-term growth model at the J.P. Morgan Healthcare Conference, highlighting signs of stabilization, anticipated margin expansion, and double-digit Adjusted EBITDA growth post-2026.

check_boxKey Events

• 2026 Financial Outlook

  The company projects consolidated gross margin and Adjusted EBITDA margin to increase by 50-100 basis points in 2026, building from a normalized Q4 2025 run rate.

• Long-Term Growth Model

  After 2026, AMN targets 4-6% annual organic revenue growth and a 10-15% CAGR for Adjusted EBITDA, with approximately 60% EBITDA to Free Cash Flow conversion.

• Signs of Stabilization

  AMN reports Q4 2025 sequential growth of 5% in Nurse and Allied solutions, improving demand for Physician and Leadership solutions, and higher enterprise client satisfaction scores.

• Strategic Focus

  The company emphasizes resuming growth in higher-margin businesses, debt paydown to reduce interest expense, and leveraging technology for efficiency and market expansion.

auto_awesomeAnalysis

The investor presentation outlines a positive trajectory for AMN Healthcare, projecting a return to growth and improved profitability. The company anticipates consolidated gross margin and Adjusted EBITDA margin expansion in 2026, building on a normalized Q4 2025 run rate. Beyond 2026, AMN targets 4-6% annual organic revenue growth and a 10-15% CAGR for Adjusted EBITDA, driven by higher-margin businesses and operating leverage. This forward-looking guidance, presented while the stock trades near its 52-week low, could signal a potential inflection point for investors.